EA200501363A1 - Состав для ингалятора, выдающего мерную дозу препарата, с использованием гидрофторалканов в качестве пропеллентов - Google Patents

Состав для ингалятора, выдающего мерную дозу препарата, с использованием гидрофторалканов в качестве пропеллентов

Info

Publication number
EA200501363A1
EA200501363A1 EA200501363A EA200501363A EA200501363A1 EA 200501363 A1 EA200501363 A1 EA 200501363A1 EA 200501363 A EA200501363 A EA 200501363A EA 200501363 A EA200501363 A EA 200501363A EA 200501363 A1 EA200501363 A1 EA 200501363A1
Authority
EA
Eurasian Patent Office
Prior art keywords
inhaler
dose
mergene
hydrofluoralkanes
propellants
Prior art date
Application number
EA200501363A
Other languages
English (en)
Other versions
EA009087B1 (ru
Inventor
Джордж Дестефано
Линда Джин Келаш - Каннаво
Original Assignee
Бёрингер Ингельхайм Фармасьютиклз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Бёрингер Ингельхайм Фармасьютиклз, Инк. filed Critical Бёрингер Ингельхайм Фармасьютиклз, Инк.
Publication of EA200501363A1 publication Critical patent/EA200501363A1/ru
Publication of EA009087B1 publication Critical patent/EA009087B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

В заявке описан улучшенный суспензионный состав, предназначенный для использования в ингаляторе, выдающем мерную дозу препарата, причем состав содержит гидрофторалкан в качестве пропеллента, а улучшение свойств состава достигается при добавлении контролируемого небольшого количества воды.
EA200501363A 2003-03-20 2004-03-19 Состав для ингалятора, выдающего мерную дозу препарата, с использованием гидрофторалканов в качестве пропеллентов EA009087B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45611303P 2003-03-20 2003-03-20
PCT/US2004/008375 WO2004084858A2 (en) 2003-03-20 2004-03-19 Formulation for a metered dose inhaler using hydro-fluoro-alkanes as propellants

Publications (2)

Publication Number Publication Date
EA200501363A1 true EA200501363A1 (ru) 2006-04-28
EA009087B1 EA009087B1 (ru) 2007-10-26

Family

ID=33098086

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200501363A EA009087B1 (ru) 2003-03-20 2004-03-19 Состав для ингалятора, выдающего мерную дозу препарата, с использованием гидрофторалканов в качестве пропеллентов

Country Status (28)

Country Link
US (1) US7914770B2 (ru)
EP (1) EP1608336B1 (ru)
JP (1) JP4708332B2 (ru)
KR (1) KR101113003B1 (ru)
CN (1) CN1761455A (ru)
AT (1) ATE390125T1 (ru)
AU (1) AU2004224367B2 (ru)
BR (1) BRPI0408547A (ru)
CA (1) CA2519523C (ru)
CO (1) CO5640070A2 (ru)
CY (1) CY1108137T1 (ru)
DE (1) DE602004012718T2 (ru)
DK (1) DK1608336T3 (ru)
EA (1) EA009087B1 (ru)
EC (1) ECSP056029A (ru)
ES (1) ES2304616T3 (ru)
HR (1) HRP20050822B1 (ru)
ME (1) ME00420B (ru)
MX (1) MXPA05009920A (ru)
NO (1) NO336457B1 (ru)
NZ (1) NZ542957A (ru)
PL (1) PL1608336T3 (ru)
PT (1) PT1608336E (ru)
RS (1) RS51663B (ru)
SI (1) SI1608336T1 (ru)
UA (1) UA89751C2 (ru)
WO (1) WO2004084858A2 (ru)
ZA (1) ZA200506463B (ru)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004011381A1 (de) * 2004-03-05 2005-09-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Impaktionsdüse für treibgasbetriebene Dosieraerosole
BRPI0512878A (pt) * 2004-07-02 2008-04-15 Boehringer Ingelheim Int formulações de suspensão de aerossol, com tg 227 ea ou tg 134 a como agente propulsor
US20060140873A1 (en) * 2004-12-27 2006-06-29 Chang Heng W Aerosol pharmaceutical compositions
GB0501956D0 (en) * 2005-01-31 2005-03-09 Arrow Internat Nebulizer formulation
GB0518769D0 (en) * 2005-09-14 2005-10-19 Medpharm Ltd Topical formulations
DE102006053374A1 (de) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
DE102006014433A1 (de) * 2006-03-27 2007-10-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Dosieraerosole für die Verabreichung von pharmazeutischen Zubereitungen
DE102006017320A1 (de) * 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
WO2008047239A2 (en) * 2006-09-21 2008-04-24 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
CA2696632C (en) * 2007-08-17 2014-05-27 Arcion Therapeutics, Inc. High concentration local anesthetic formulations
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
WO2010019953A1 (en) 2008-08-15 2010-02-18 Arcion Therapeutics, Inc. High concentration local anesthetic formulations for treating non-neuropathic pain
EP2662472B1 (de) 2009-03-31 2019-02-27 Boehringer Ingelheim International Gmbh Verfahren zur Beschichtung einer Oberfläche eines Bauteils
US9265910B2 (en) 2009-05-18 2016-02-23 Boehringer Ingelheim International Gmbh Adapter, inhalation device, and nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
EP2504052B1 (en) 2009-11-25 2022-07-27 Boehringer Ingelheim International GmbH Nebulizer
EP2585151B1 (en) 2010-06-24 2018-04-04 Boehringer Ingelheim International GmbH Nebulizer
US20120204871A1 (en) * 2011-02-10 2012-08-16 Julio Cesar Vega Stable, non-corrosive formulations for pressurized metered dose inhalers
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
CN102798044B (zh) * 2012-08-02 2014-09-10 深圳市华星光电技术有限公司 侧入式背光模组
ES2836977T3 (es) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizador
EP3030298B1 (en) 2013-08-09 2017-10-11 Boehringer Ingelheim International GmbH Nebulizer
RS64124B1 (sr) 2014-05-07 2023-05-31 Boehringer Ingelheim Int Inhalator i kontejner
DK3139984T3 (da) 2014-05-07 2021-07-19 Boehringer Ingelheim Int Forstøver
ES2954961T3 (es) 2014-05-07 2023-11-27 Boehringer Ingelheim Int Unidad, nebulizador y método
US20180071231A1 (en) * 2015-04-10 2018-03-15 3M Innovative Properties Company Formulation and aerosol canisters, inhalers, and the like containing the formulation
GB2573297A (en) * 2018-04-30 2019-11-06 Mexichem Fluor Sa De Cv Pharmaceutical composition
US20230271770A1 (en) * 2020-04-21 2023-08-31 Amphastar Pharmaceuticals, Inc. Anti-Viral Pharmaceutical Formulations Administered Via Devices for Lung Targeted Delivery

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405598A (en) * 1976-01-30 1983-09-20 Fisons, Limited Composition for treating asthma
GB8824804D0 (en) * 1988-10-22 1988-11-30 Fisons Plc Device
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5919435A (en) * 1990-11-09 1999-07-06 Glaxo Group Limited Aerosol formulation containing a particulate medicament
GB9202519D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
AU6048694A (en) * 1992-12-09 1994-07-04 Paul D. Jager Stabilized medicinal aerosol solution formulations
DE69701051T2 (de) * 1993-04-30 2000-08-31 Minnesota Mining & Mfg Abdichtung an Aerosolbehältern
DE69412626T2 (de) 1993-07-15 1999-01-28 Minnesota Mining & Mfg Dichtungen für eine vorrichtung zum abgeben eines aerosols
ATE258813T1 (de) * 1995-04-14 2004-02-15 Smithkline Beecham Corp Vorrichtung zur dosierten inhalierung von beclomethason-diproprionat
GB9513084D0 (en) 1995-06-27 1995-08-30 Bespak Plc Dispensing apparatus
SE9701750D0 (sv) * 1997-05-12 1997-05-12 Astra Pharma Prod Inhalation device and method of manufacture thereof
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
GB2326334A (en) * 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
US6423298B2 (en) * 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
NZ509489A (en) * 1998-08-04 2002-10-25 Jago Res A Medicinal aerosol formulations comprising cromoglycic acid and/or nedocromil
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1303788B1 (it) 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
US6261539B1 (en) 1998-12-10 2001-07-17 Akwete Adjei Medicinal aerosol formulation
US7074388B2 (en) * 1998-12-10 2006-07-11 Kos Life Science, Inc. Water stabilized medicinal aerosol formulation
US20030008369A1 (en) * 1999-03-03 2003-01-09 Board Of Regents, The University Of Texas System Genetic and epigenetic manipulation of ABC transporters and ecto-phosphatases
GB0002798D0 (en) * 2000-02-09 2000-03-29 Glaxo Group Ltd Actuator nozzle for metered dose inhaler
EP1241113A1 (en) 2001-03-12 2002-09-18 CHIESI FARMACEUTICI S.p.A. Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein
ATE506093T1 (de) 2001-06-26 2011-05-15 Norton Healthcare Ltd Verbesserter aerosol-regler

Also Published As

Publication number Publication date
US7914770B2 (en) 2011-03-29
PT1608336E (pt) 2008-04-21
KR20050111382A (ko) 2005-11-24
SI1608336T1 (sl) 2008-08-31
EP1608336B1 (en) 2008-03-26
AU2004224367B2 (en) 2009-10-08
PL1608336T3 (pl) 2008-09-30
MXPA05009920A (es) 2005-11-04
EA009087B1 (ru) 2007-10-26
ATE390125T1 (de) 2008-04-15
CN1761455A (zh) 2006-04-19
CA2519523A1 (en) 2004-10-07
ZA200506463B (en) 2006-04-26
NO20054839L (no) 2005-10-19
HRP20050822A2 (en) 2006-10-31
UA89751C2 (ru) 2010-03-10
ES2304616T3 (es) 2008-10-16
ECSP056029A (es) 2006-01-27
KR101113003B1 (ko) 2012-02-24
DK1608336T3 (da) 2008-06-02
CY1108137T1 (el) 2014-02-12
DE602004012718D1 (de) 2008-05-08
US20040184994A1 (en) 2004-09-23
WO2004084858A3 (en) 2004-11-04
NZ542957A (en) 2008-09-26
DE602004012718T2 (de) 2009-05-07
EP1608336A2 (en) 2005-12-28
AU2004224367A1 (en) 2004-10-07
RS51663B (en) 2011-10-31
RS20050705A (en) 2008-04-04
BRPI0408547A (pt) 2006-03-07
HRP20050822B1 (hr) 2013-09-30
WO2004084858A2 (en) 2004-10-07
ME00420B (me) 2011-12-20
JP2006520797A (ja) 2006-09-14
JP4708332B2 (ja) 2011-06-22
NO336457B1 (no) 2015-08-31
CA2519523C (en) 2012-03-13
CO5640070A2 (es) 2006-05-31

Similar Documents

Publication Publication Date Title
EA200501363A1 (ru) Состав для ингалятора, выдающего мерную дозу препарата, с использованием гидрофторалканов в качестве пропеллентов
BRPI0417717A (pt) composto, composição farmacêutica, e, uso de um composto
BR0312560A (pt) Novas espiropiperidinas ou espiropirrolidinas tricìclicas
UY27740A1 (es) Nuevos compuestos
EA200600620A1 (ru) Набор для ингаляции с ингаляционным порошком, содержащим тиотропий
TW200616661A (en) HER2 antibody composition
IS6658A (is) Ný efnasambönd
TW200716529A (en) New compounds II
TW200626553A (en) Novel compounds
NO20051187L (no) Depotformuleringer bestaende av aktive arylheterocykliske forbindelser i form av en suspensjon
MY163503A (en) Aerosol formulations for the inhalation of beta agonists
RS99804A (en) Novel compounds and their use
UY29169A1 (es) Derivados de 2-amido-4 feniltiazol, su preparacion y su aplicacion en terapeutica
TW200736227A (en) New compounds III
BRPI0412320A (pt) uso de um agente modificador de reologia, e composições de revestimento
SE0302139D0 (sv) Novel compounds
SE0403171D0 (sv) New compounds
SE0303541D0 (sv) New compounds
SE0300092D0 (sv) Novel compounds
SE0300091D0 (sv) Novel compounds
SE0102716D0 (sv) Novel compounds
TW200720262A (en) Novel compounds ii
SE0403118D0 (sv) New compounds 2
CL2004001579A1 (es) Composicion farmaceutica que comprende un analogo de somatostatina y acido tartarico, donde la composicion tiene el ph regulado entre 4 y 4,5 y el compuesto activo es l ciclo[{4-(nh2-c2h4-nh-cp-o)pro}-phg-dtrp-lys-tyr(4-bzl)-phe]; y su uso para prepa
SE0403117D0 (sv) New compounds 1